3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Salivary Gland Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Advanced Malignancies
1
Interventions
Oxaliplatin
9
Leucovorin
8
Fluorouracil
8
Cetuximab
6
Bevacizumab
5
Specimen Handling
4
Pemetrexed
4
pembrolizumab
3
fludarabine
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
Cisplatin
3
Carboplatin
3
encorafenib
2
dehydroftorafur
2
aldesleukin
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Disulfides
2
Celecoxib
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
zanidatamab
×
30 days
×
Clear all
No trials found.